Peroxisome proliferator activated receptor γ expression is reduced in the colonic mucosa of acromegalic patients

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 2403-2406

  Bogazzi, Fausto ^a,b   Ultimieri, Federica ^a,b   Raggi, Francesco ^a,b   Costa, Aurelio ^a,b   Gasperi, Maurizio ^a,b   Cecconi, Elisabetta ^a,b   Mosca, Franco ^a,b   Bartalena, Luigi ^a,b   Martino, Enio ^a,b,c  

^a Department of Endocrinology and Metabolism ^*  (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SANDOSTATINA LAR; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADIPOCYTE; ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLON MUCOSA; COLON POLYP; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HORMONAL THERAPY; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; REMISSION;

ACROMEGALY; ADULT; COLON; COLONIC POLYPS; FEMALE; GENE DOSAGE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; REMISSION INDUCTION; RNA, MESSENGER; SOMATOSTATIN; TRANSCRIPTION FACTORS;

EID: 0036092987     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.5.2403     Document Type: Article

References (24)

1. The nuclear receptor superfamily: The second decade
2. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator activated receptors and liver X receptor alpha in humans: No alteration in adipose tissue of obese and NIDDM patients
3. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function
4. Differentiation and reversal of malignant changes in colon cancer through PPARγ
5. Ligands for peroxisome proliferator activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and BNX mice
6. The organization, promoter analysis, and expression of the human PPARgamma gene
7. Ligands for peroxisome proliferator activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats
8. Loss-of-function mutations in PPAR gamma associated with human colon cancer
9. PAX8-PPARgamma 1 fusion oncogene in human thyroid carcinoma
10. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
11. Ligand for peroxisome proliferator-activated receptor g (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
12. Acromegaly, colonic polyps and carcinoma
13. Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly
14. Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide
15. Increased epithelial cell proliferation in the colon of patients with acromegaly
16. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly
17. Prospective study of colorectal cancer risk in men and plasma levels of insulin like growth factor (IGF)-1 and IGF binding protein-3
18. Cellular responses to interferons and other cytokines: The JAK-STAT paradigm
19. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α
20. Target genes of peroxisome proliferator-activated recepto γ in colorectal cancer cells
21. An adipogenic cofactor bound by the differentiation domain of PPAR gamma
22. Risk of colorectal neoplasia in acromegaly: An independent view
23. Colorectal neoplasia in acromegaly
24. Screening colonscopy for acromegaly in perspective